Tet Matsuguchi
Papers
2
Total Citations
153
H-Index
2
About
Tet Matsuguchi is a leading figure in the development of high-throughput platforms for recombinant antibody generation, a field critical to both basic research and clinical diagnostics. Their most influential work, a 2015 paper with 120 citations, describes an industrialized pipeline for producing validated recombinant antibodies against 346 transcription factors, directly addressing the critical shortage of renewable, sequence-defined reagents. This breakthrough was further supported by a second highly-cited paper (33 citations) detailing scalable selection methods from phage-displayed synthetic antibody libraries. Together, these contributions have established a robust, permanent alternative to traditional monoclonal technologies, enabling researchers to bypass the limitations of hybridoma-derived antibodies. Matsuguchi’s work is notable for its systematic approach to a long-standing bottleneck in proteomics and cell biology, providing the community with standardized, high-quality tools that dramatically improve experimental reproducibility and throughput. Their platform represents a paradigm shift, moving antibody production from an artisanal craft to an industrialized, scalable science.
Research Focus
Key Achievements
Top Papers
- 1A High Through-put Platform for Recombinant Antibodies to Folded Proteins120 citations · 2015
- 2